Cargando…
Crosstalk between COVID-19 and prostate cancer
A new coronavirus, named SARS-CoV-2, emerged in Wuhan city, China, in December 2019 causing atypical pneumonia and affecting multiple body organs. The rapidly increasing numbers of infected patients and deaths due to COVID-19 disease necessitated declaring it as a global pandemic. Efforts were combi...
Autores principales: | Bahmad, Hisham F., Abou-Kheir, Wassim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378980/ https://www.ncbi.nlm.nih.gov/pubmed/32709978 http://dx.doi.org/10.1038/s41391-020-0262-y |
Ejemplares similares
-
Prostate Cancer and Aspirin Use: Synopsis of the Proposed Molecular Mechanisms
por: Bilani, Nadeem, et al.
Publicado: (2017) -
Epithelial-to-Mesenchymal Transition-Related Markers in Prostate Cancer: From Bench to Bedside
por: Gogola, Samantha, et al.
Publicado: (2023) -
Cancerona: Challenges of Cancer Management in Times of COVID-19 Pandemic
por: Ballout, Farah, et al.
Publicado: (2020) -
Genome-wide gene expression analysis of a murine model of prostate cancer progression: Deciphering the roles of IL-6 and p38 MAPK as potential therapeutic targets
por: Daouk, Reem, et al.
Publicado: (2020) -
Cancer Stem Cells in Neuroblastoma: Expanding the Therapeutic Frontier
por: Bahmad, Hisham F., et al.
Publicado: (2019)